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Abstract
Host defense against the parasite Toxoplasma gondii requires the cytokine interferon-gamma (IFNc). However, Toxoplasma
inhibits the host cell transcriptional response to IFNc, which is thought to allow the parasite to establish a chronic infection.
It is not known whether all strains of Toxoplasma block IFNc-responsive transcription equally and whether this inhibition
occurs solely through the modulation of STAT1 activity or whether other transcription factors are involved. We find that
strains from three North American/European clonal lineages of Toxoplasma, types I, II, and III, can differentially modulate
specific aspects of IFNc signaling through the polymorphic effector proteins ROP16 and GRA15. STAT1 tyrosine
phosphorylation is activated in the absence of IFNc by the Toxoplasma kinase ROP16, but this ROP16-activated STAT1 is not
transcriptionally active. Many genes induced by STAT1 can also be controlled by other transcription factors and therefore
using these genes as specific readouts to determine Toxoplasma inhibition of STAT1 activity might be inappropriate. Indeed,
GRA15 and ROP16 modulate the expression of subsets of IFNc responsive genes through activation of the NF-kB/IRF1 and
STAT3/6 transcription factors, respectively. However, using a stable STAT1-specific reporter cell line we show that strains
from the type I, II, and III clonal lineages equally inhibit STAT1 transcriptional activity. Furthermore, all three of the clonal
lineages significantly inhibit global IFNc induced gene expression.
Citation: Rosowski EE, Saeij JPJ (2012) Toxoplasma gondii Clonal Strains All Inhibit STAT1 Transcriptional Activity but Polymorphic Effectors Differentially
Modulate IFNc Induced Gene Expression and STAT1 Phosphorylation. PLoS ONE 7(12): e51448. doi:10.1371/journal.pone.0051448
Editor: Ira Blader, University of Oklahoma Health Sciences Center, United States of America
Received August 10, 2012; Accepted November 1, 2012; Published December 11, 2012
Copyright:  2012 Rosowski, Saeij. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: J. Saeij was supported by National Institutes of Health R01-AI080621 and by a Scientist Development Grant from the American Heart Association
(0835099N). E. Rosowski was supported by a pre-doctoral grant in the Biological Sciences (5-T32- GM007287-33) and the Cleo and Paul Schimmel Fund. The
funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: jsaeij@mit.edu
Introduction
The cytokine interferon-gamma (IFNc) and the transcription
factor it activates, signal transducer and activator of transcription
(STAT) 1, are critical to host defense against the obligate
intracellular parasitic pathogen Toxoplasma gondii; mice deficient
in elements of this pathway are acutely susceptible to Toxoplasma
infection [1–3]. Activated STAT1 induces the expression of genes
with gamma activated sequence (GAS) elements in their
promoters, including the interferon regulatory factor (IRF) 1
transcription factor. STAT1 and IRF1 together induce a broad
transcriptional program including effector mechanisms that
mediate pathogen destruction or inhibition of pathogen growth
[4].
However, Toxoplasma infection can inhibit IFNc induced gene
expression in host cells, and was first shown to inhibit the basal and
IFNc induced expression of MHC class II molecules, in a variety
of cell types [5–7]. Since then, Toxoplasma has also been shown to
inhibit the expression of IRF1 [8,9], class II transactivator (CIITA)
[7–9], inducible nitric oxide synthase (iNOS/NOS2) [10,11],
interferon inducible GTPase 1 (IIGP1) [12], and chemokine (C-X-
C motif) ligand 9 (MIG/CXCL9) [12]. This inhibition occurs in
a variety of cell types, including human foreskin fibroblasts (HFF),
human glioblastoma cells, murine bone marrow-derived macro-
phages (BMDM), RAW264.7 murine macrophages, murine
dendritic cells, and murine microglial cells. Microarray analyses
showed that Toxoplasma infection can dysregulate the entire IFNc
induced gene expression program in both HFFs [13] and BMDMs
[14].
Toxoplasma infects virtually all warm-blooded animals, including
,30% of the worldwide human population [15]. Many different
strains of Toxoplasma have been isolated from various hosts, and in
North America and Europe the majority of Toxoplasma isolates
from humans and livestock belong to three main clonal lineages:
types I, II, and III [16]. These strains differ in the modulation of
multiple host cell signaling pathways through polymorphic
effectors secreted into the host cell from rhoptry and dense
granule organelles [17]. While all of these strains can inhibit the
expression of at least certain IFNc induced genes, it is unknown
whether all of the strains can inhibit global IFNc induced gene
expression and STAT1 transcriptional activity, or whether the
degree of inhibition varies between Toxoplasma strains.
Many STAT1 regulated genes can be induced or repressed by
other transcription factors, for example NF-kB and STAT3/6,
and such genes might not be the best readouts to determine if
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Toxoplasma specifically inhibits STAT1 activity. Another question
that is still unanswered is whether the activation of other
transcription factors by Toxoplasma affects the IFNc response.
Specifically, the modulation of STAT3/6 and NF-kB transcription
factors through the effector proteins ROP16 [18] and GRA15
[19], respectively, might affect this response.
The polymorphic rhoptry kinase ROP16 from type I and III
strains activates the transcription factors STAT3 and STAT6
[18,20,21]. In STAT3 deficient cells [22] or cells with STAT6
knocked down [23], increased transcription of STAT1 target
genes has been found, suggesting that STAT3 and STAT6 can
antagonize STAT1 activity. STAT6 can also compete for
promoter sites with STAT1 [24]. It is therefore possible that the
activation of STAT3/6 by ROP16 helps to suppress IFNc induced
signaling.
SOCS family proteins are important negative regulators of the
IFNc response and in Socs12/2 BMDM, Toxoplasma could not
inhibit the IFNc response as well as in wild-type BMDM [12].
ROP16 is a strong activator of SOCS family gene expression; in
murine BMDM, Socs1, 2, and 3 are more than 10-fold induced by
ROP16 expression [25]. It is therefore possible that ROP16 plays
a role in the inhibition of the IFNc response through the induction
of Socs genes. Furthermore, the expression of genes that are co-
regulated by both STAT1 and STAT3/6 transcription factors
could also be affected by ROP16. If the expression level of such
a gene was chosen to measure STAT1 activity, incorrect
conclusions might be drawn.
The type II version of the dense granule protein GRA15
activates the host cell NF-kB pathway [19]. NF-kB also co-
regulates many of the same genes as STAT1, and NF-kB
activation combined with STAT1 activation synergistically in-
duces IRF1 expression and activity [26]. It is therefore possible
that strains possessing an active copy of GRA15 do not inhibit
IFNc induced gene expression as well as other strains, or
differentially inhibit subsets of IFNc responsive genes. In fact,
a type II Dgra15 strain grows faster in vivo than a type II strain [19],
and GRA15 corresponds to a Toxoplasma virulence locus [19,27].
In this report we show that the polymorphic effectors GRA15
and ROP16 do contribute to strain differences in the modulation
of IFNc-STAT1 signaling. Type II GRA15 induces the expression
of IRF1, which can induce a subset of IFNc responsive genes.
ROP16 induces the tyrosine phosphorylation and nuclear trans-
location of STAT1 but this STAT1 is not transcriptionally active.
In spite of these differences, type I, II, and III parasites can all
inhibit global IFNc induced transcription as determined by
microarray analysis. Because many STAT1-regulated genes can
be controlled by other transcription factors we directly measured
STAT1 activity with a stable STAT1-specific reporter cell line and
find that neither GRA15 nor ROP16 affects the ability of
Toxoplasma to inhibit STAT1 transcriptional activity.
Materials and Methods
Parasites and Cells
Parasites were maintained in vitro by serial passage on mono-
layers of human foreskin fibroblasts (HFFs), as described pre-
viously [19]. RH or GT1 were used as representative type I strains,
Pru or ME49 as representative type II strains and CEP or VEG as
representative type III strains. A Pru strain engineered to express
firefly luciferase and GFP (Pru Dhxgprt A7) [28], and CEP and RH
strains engineered to express clickbeetle luciferase and GFP (CEP
hxgprt 2 C22 and RH 1–1) [29] have been described previously.
An RH Drop16 strain (provided by John Boothroyd, Stanford
University) [21], an RH Drop16 strain expressing firely luciferase
and GFP (clone 1A2) [25], a PruA7 ROP16I strain [25], and Pru
Dgra15, PruA7 Dgra15, and RH GRA15II strains [19] have been
described previously. HFFs (provided by John Boothroyd,
Stanford University) and RAW264.7 (ATCC) cells were grown
as described previously [19,25]. 293FT and HEK293 cells were
grown with additional 10 mM HEPES. U3A STAT1-null cells
[30,31] (provided by George Stark, Cleveland Clinic Foundation
Research Institute, Ohio) were grown with 10 mM HEPES,
1 mM sodium pyruvate, and MEM non-essential amino acids. All
parasite strains and cell lines were routinely checked for
Mycoplasma contamination and it was never detected.
Reagents
Antibodies against IRF1 (BD Biosciences #612046), phospho-
STAT1Tyr701 58D6 (Cell Signaling #9167), phospho-STAT1-
Ser727 (Cell Signaling #9177), total STAT1a p91 (C-24) (Santa
Cruz#345), GAPDH (6C5) (Santa Cruz #32233), and Toxoplasma
surface antigen (SAG)-1 (kindly provided by John Boothroyd,
Stanford University) were used in immunofluorescence and
Western blot assays. Secondary antibodies coupled with either
Alexa Fluor 488 or Alexa Fluor 594 (Molecular Probes) for
immunofluorescence assay or conjugated to peroxidase (Kirke-
gaard & Perry Laboratories) for Western blots were used.
Recombinant human IFNc (100 U/ml, AbD serotec) and murine
IFNc (100 U/ml, Calbiochem) were used to stimulate cells.
Immunofluorescence Assay
Immunofluorescence assay was performed as described pre-
viously [19]. Briefly, cells were fixed with 3% formaldehyde,
permeabilized with 100% ethanol and/or 0.2% Triton-X 100,
and blocked with 3% BSA and 5% goat serum. Coverslips were
incubated with primary antibody at 4uC, and fluorescent
secondary antibodies and Hoechst dye were used for antigen
and DNA visualization, respectively. Photographs were taken
using NIS-Elements software (Nikon) and a digital camera
(Coolsnap EZ; Roper Scientific) connected to an inverted
fluorescence microscope (model eclipse Ti-S; Nikon). Quantifica-
tion of nuclear signal was performed by randomly selecting cells in
each condition and measuring the average signal intensity per
nucleus using the NIS-Elements software and Hoechst dye to
define nuclei. The minimum number of cells measured is indicated
in the figure legends for each experiment.
Western Blot
Western blots were performed as described previously [19].
Briefly, HFFs were left uninfected or infected with RH Dhxgprt,
RH 1–1, RH Drop16, RH Drop16 1A2, Pru Dhxgprt A7, or CEP
hxgprt - C22 parasites for three hours. Samples were subsequently
stimulated with human IFNc for one hour, or left unstimulated,
and then lysed in buffer containing sodium dodecyl sulfate (SDS)
and either b-mercaptoethanol (bME) or dithiothreitol (DTT).
After immunoblotting, membranes were stripped with boiling 2%
SDS and 0.7% bME and reprobed.
Reporter Cell Line Construction
A GAS (TR027PA-1, 59-AGTTTCATATTACTCTAAATC -
39) pGreenFire1 (pGF1) lentiviral reporter vector containing a Neo
selection cassette and a minimal CMV promoter followed by four
tandem consensus GAS sites driving the expression of Firefly
luciferase was purchased from System Biosciences. The vector was
co-transfected into 293FT cells with vectors containing gag, pol,
and VSV-G proteins using FuGENE reagent (Roche) according to
the manufacturer’s protocol. Supernatant containing virus was
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collected two and three days after transfection, filtered with
a 0.45 mm surfactant-free cellulose acetate filter (Nalgene), and
added to HEK293 cells (ATCC) with 8 mg/ml polybrene (Sigma).
HEK293 cells containing the pGF1 construct were then selected
with 750 mg/ml Geneticin (Invitrogen). Cells were cloned by
limiting dilution and were confirmed to be responsive to IFNc but
not to IFNb, TNFa, or IL4.
Luciferase Assay
HEK293 pGF1-GAS cells were plated in 96-well plates, 3.5–
46104 cells/well, and grown for 4–20 hours. Cells were then
infected with RH Dhxgprt, RH Drop16, GT1, Pru Dhxgprt, Pru
Dgra15, ME49, CEP Dhxgprt, or VEG parasites at varying MOIs
for 1–4 hours, and subsequently stimulated with human IFNc for
12–24 hours. Cells were lysed with 20 ml Cell Culture Lysis
Reagent (Promega) containing 16protease inhibitors (Roche), and
plates were frozen at 280uC. Luciferase activity in plates was
detected using a Varioskan Flash Reader (Roche) after addition of
100 ml Luciferase assay substrate (Promega), according to the
manufacturer’s instructions. Data were normalized to the un-
infected, unstimulated sample and averaged over at least two
experiments per condition.
Microarray
1.56106 RAW264.7 cells were plated in 6-well plates and
grown for 24 hours. The cells were then left uninfected or infected
with RH 1–1, Pru Dhxgprt A7, or CEP hxgprt- C22 parasites at an
MOI ,5 for 18 hours and subsequently stimulated with murine
IFNc for six hours. The RH infection was done at one time and
Pru and CEP infections were done together at a later time.
Uninfected controls were included for both sets of infections. RNA
was isolated and microarray analysis, including analysis with the
DiRE server, was performed as described previously [19], with
Mouse 430A 2.0 Affymetrix gene chips. Microarray data has been
uploaded to NCBI Gene Expression Omnibus and are accessible
through GEO Series accession number GSE34913.
Plaque Assay
For Western blot, luciferase reporter, and microarray assays,
a plaque assay was done to determine the viability of each strain
and the actual MOI. One hundred parasites per well were added
to confluent HFFs in a 24-well plate and were incubated
undisturbed for 5–7 days at 37uC, and the number of plaques
was counted. Samples with similar MOIs were then picked for
analysis.
Results
A Type II Strain Activates IRF1 via GRA15 and NF-kB
Infection of HFFs with a type II Pru strain of Toxoplasma was
previously shown to induce the expression of 46 genes that were
also defined as IFNc regulated [13], raising the possibility that type
II strains are not as good at inhibiting IFNc induced gene
expression as other clonal lineages. To compare the ability of type
I, II, and III strains to inhibit the IFNc response we pre-infected
HFFs with RH(I), Pru(II), or CEP(III) strains, or left cells
uninfected, and subsequently stimulated the cells with IFNc or
left them unstimulated. We then visualized and quantified the
amount of IRF1 in the nucleus by immunofluorescence. IRF1 is
a primary response gene induced directly by STAT1 upon IFNc
stimulation. After three hours of infection, with IFNc stimulation
for the last two hours, cells pre-infected with either RH(I), Pru(II),
or CEP(III) all had significantly lower levels of IRF1 in their nuclei
than uninfected cells (Fig. 1A, B), as was previously seen for type I,
II, and III strains [8,9,13]. However, after 24 hours of infection,
with IFNc stimulation for the last six hours, while RH(I), Pru(II),
and CEP(III) infection all significantly inhibited IRF1 expression
compared to uninfected cells, cells pre-infected with a Pru(II) strain
had significantly higher IRF1 in their nuclei than cells pre-infected
with a RH(I) strain (Fig. 1A, B). Cells pre-infected with a Pru(II)
strain also had higher levels of IRF1 than cells pre-infected with
a CEP(III) strain but this difference was not statistically significant.
These data suggest that a Pru(II) strain does not inhibit IRF1
expression as well as RH(I) or CEP(III) strains.
We next determined IRF1 levels after infection in the absence of
IFNc. In unstimulated cells infected with Pru(II) for 24 hours, we
find ,2.5 fold higher nuclear IRF1 levels than in uninfected cells
or cells infected with either RH(I) or CEP(III) (Fig. 1A, B). These
data suggest that the different IRF1 protein levels observed in
Pru(II) and RH(I) infected cells after IFNc treatment may not be
due to differences in the ability of these strains to inhibit IFNc
induced gene expression but instead due to the induction of IRF1
by Pru(II) infection, independently of IFNc.
Although IRF1 is primarily induced by interferons it also has
three NF-kB binding sites in its promoter [4] and these are
important for the synergistic induction of genes by IFNc and
TNFa [26]. Type II parasites activate NF-kB-mediated transcrip-
tion via the dense granule protein GRA15 [19] and we
hypothesized that GRA15-mediated NF-kB activation could drive
the expression of IRF1. To test this hypothesis, we also infected
HFFs with a PruDgra15 strain (Fig. 1A, B). After 24 hours of
infection, this strain induced significantly less IRF1 protein than
a Pru strain (p,0.001) and PruDgra15 infected cells have similar
IRF1 levels as cells infected with RH(I) and CEP(III) strains which
possess inactive copies of GRA15 [19]. An RH(I) strain ectopically
expressing a type II copy of GRA15 also induced IRF1 expression
in HFF host cells (Fig. 1C).
To determine whether this GRA15-mediated activation of IRF1
is dependent on STAT1, we infected U3A STAT1-deficient cells
[30,31] with either Pru(II) or PruDgra15 parasites, or stimulated
the cells with IFNc. While IFNc treatment, which relies on
STAT1 signaling, does not activate IRF1 expression in these cells,
infection with Pru(II) parasites does, and this activation is again
dependent on the presence of GRA15 (Fig. 1D), demonstrating
that the GRA15-mediated induction of IRF1 is through a different
transcription factor. GRA15 is known to activate the NF-kB p65
transcription factor [19], and since it is also known that NF-kB can
activate the expression of IRF1 [4,26], we hypothesized that
GRA15 was inducing IRF1 through the activation of NF-kB p65.
Indeed, in a previous microarray analysis [19], while Irf1 transcript
was induced by infection of wild-type MEFs with GRA15-
expressing Pru(II) parasites, infection with this strain did not
induce Irf1 transcript in p652/2 MEFs, strongly suggesting that
induction of IRF1 expression by GRA15 is through the NF-kB
p65 transcription factor.
IRF1 is itself a transcription factor and to test whether GRA15
might be responsible for more than just the expression of IRF1,
but also the expression of other IFNc regulated genes that were
found to be induced by Pru infection [13], we re-analyzed the
microarray data from which this observation was made. We found
775 oligonucleotide probes that were at least two-fold induced in
HFFs by IFNc treatment and by Pru infection. These 775 probes
correspond to 374 genes also present in a microarray analysis of
HFFs infected with GRA15-deficient and GRA15-overexpressing
Toxoplasma strains [19]. Of these 374 genes, 43 were previously
found to be at least two-fold GRA15-regulated in at least one
parasite genetic background [19], a significant enrichment
(p = 0.03, hypergeometric test), indicating that GRA15 does
Toxoplasma Effectors Modulate the IFNc Response
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induce the expression of a subset of IFNc responsive genes (Data
S1). Therefore, while type I, II, and III Toxoplasma strains can all
inhibit the IFNc induced expression of IRF1, type II strains also
induce IRF1 expression, independently of STAT1, most likely
through GRA15-mediated activation of NF-kB p65. This IRF1
induction also leads to the expression of a small subset of other
IFNc responsive genes.
Toxoplasma Infection Affects STAT1 Phosphorylation
After IFNc treatment, STAT1 is tyrosine phosphorylated in the
cytoplasm which allows it to traffic to the nucleus. Most recently, it
was shown that infection of cells with type II Pru [13] or NTE
parasites [9,14] does not inhibit IFNc-induced STAT1 trafficking
into the nucleus. Previously however, the nuclear translocation of
STAT1 was reported to be inhibited by type II (NTE) Toxoplasma
infection [8]; the tyrosine phosphorylation of STAT1 was reported
to be inhibited by type I (BK) infection [12], and type I (RH), type
II (Pru), and type III (CL14) Toxoplasma strains were suggested to
cause dephosphorylation of STAT1 in the nucleus [13].
To determine if there are strain differences in the effect of
infection on IFNc-induced STAT1 phosphorylation and localiza-
tion, we infected HFFs for one hour with either RH(I), Pru(II), or
CEP(III) parasites, subsequently stimulated the cells for two hours
with IFNc, and quantified STAT1 tyrosine phosphorylation and
nuclear translocation by immunofluorescence (Fig. 2A, B).
Quantification of the immunofluorescence signal revealed that
Figure 1. Type II GRA15 affects the expression of IRF1. HFFs were infected with RH(I), RH GRA15II, Pru(II), PruDgra15, or CEP(III) parasites and/or
stimulated with 100 U/ml IFNc, subsequently fixed and permeabilized and stained with an antibody against IRF1 (red) and with Hoechst dye (blue,
nucleus). A, B. HFFs were infected for three or 24 hours with GFP-expressing parasites (green), or left uninfected, and stimulated with IFNc for the last
two or six hours, or left unstimulated. Nuclear localization of IRF1 was quantified in at least 12 randomly selected cells per condition and normalized
to uninfected, unstimulated cells (A) and a representative cell for each condition is shown (B). Scale bar represents 10 mm. This experiment was
performed three times with similar results. Data and standard deviation from one representative experiment are shown. Asterisk (*) indicates p,0.05
compared to uninfected cells, dollar sign ($) indicates p,0.05 compared to type II infected cells. C. HFFs were infected with an RH(I) or RH GRA15II
strain, left uninfected, or left uninfected and stimulated with IFNc for 24 hours. Nuclear localization of IRF1 was quantified in at least 30 randomly
selected cells and normalized to uninfected, unstimulated cells. Data and standard deviation from one experiment are shown. Asterisk (*) indicates
p,0.05 compared to uninfected cells or as represented by brackets. D. U3A STAT1-deficient cells were infected with Pru(II) or PruDgra15 parasites for
20 hours, left uninfected, or stimulated with IFNc for 1 hour. Nuclear localization of IRF1 was quantified in at least 8 randomly selected cells per
condition, and normalized to uninfected, unstimulated cells. This experiment was performed twice with similar results, data from one representative
experiment are shown. Asterisk (*) indicates p,0.05 compared to uninfected cells, dollar sign ($) indicates p,0.05 compared to type II infected cells.
doi:10.1371/journal.pone.0051448.g001
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levels of IFNc induced nuclear phospho-STAT1Tyr were actually
higher in infected cells compared to uninfected cells (Fig. 2A). We
therefore find that none of the tested Toxoplasma strains inhibit the
tyrosine phosphorylation or nuclear accumulation of phospho-
STAT1Tyr after IFNc treatment, which agrees with the majority of
previous results.
Since we observed higher levels of phospho-STAT1Tyr in
infected cells as compared to uninfected cells after IFNc
stimulation, we wondered whether infection with type I, II, or
III parasites induces nuclear phospho-STAT1Tyr in the absence of
IFNc. We infected HFFs for three hours with either RH(I), Pru(II),
or CEP(III) parasites, and quantified STAT1 tyrosine phosphor-
ylation and nuclear translocation by immunofluorescence. Indeed,
we observed nuclear phospho-STAT1Tyr in unstimulated cells
infected with three or more RH(I) or CEP(III) parasites, and to
a lower level in cells infected with three or more Pru(II) parasites
(Fig. 2B). We quantified this signal in cells infected with three or
more parasites and find that infection results in a significant
increase in nuclear phospho-STAT1Tyr levels in RH(I) and
CEP(III) infected cells (Fig. 2A). Pru(II) infection also significantly
induces phospho-STAT1Tyr, although not as highly as RH(I) or
CEP(III) parasites (Fig. 2A).
We next sought to determine what parasite factor induces
phospho-STAT1Tyr after host cell infection. It is known that the
secreted rhoptry kinase ROP16 from type I and III strains can
directly tyrosine phosphorylate STAT3 and STAT6 [20,21]. The
first 700 amino acid residues of STATs 1–6 share up to 40%
identity [32], raising the possibility that ROP16 also induces the
tyrosine phosphorylation of STAT1. To determine if ROP16 is
required for the tyrosine phosphorylation of STAT1 by RH(I)
parasites in non-IFNc-stimulated conditions, we also infected
HFFs with RHDrop16 parasites and again visualized phospho-
STAT1Tyr nuclear accumulation by immunofluorescence. As
compared to cells infected with RH(I) parasites, cells infected
with RHDrop16 parasites had significantly less phospho-STAT1Tyr
in their nuclei, with levels almost as low as in uninfected cells
(Fig. 2A, B). We next infected HFFs with a Pru strain that
overexpresses the type I copy of ROP16. The ectopic expression of
ROP16I in a type II background led to an increase in phospho-
STAT1Tyr after infection (Fig. 2A, B). However, deletion of
ROP16 from a type I parasite background or overexpression of
ROP16I in a type II parasite background did not affect the level of
phospho-STAT1Tyr in infected cells after IFNc treatment, in-
dicating that the increase in phospho-STAT1Tyr in infected cells
after IFNc stimulation occurs independently of ROP16 (Fig. 2A,
B). Together, these results demonstrate that in the absence of
IFNc, ROP16 can induce the tyrosine phosphorylation of STAT1.
ROP16 Activated STAT1 is not Transcriptionally Active
Our results indicate that ROP16 can directly activate STAT1
and it is therefore possible that strains with an active ROP16 (I
and III) might be less efficient in inhibiting IFNcmediated STAT1
activation. On the other hand, ROP16 also activates STAT3 and
STAT6, both of which can induce SOCS gene expression, which
might inhibit IFNc-STAT1 signaling [33,34]. Indeed, we pre-
viously showed that Socs1, a potent inhibitor of the IFNc-STAT1
signaling pathway, is one of the host genes most highly induced by
ROP16 expression [25]. To determine if ROP16 might play a role
in the modulation of the IFNc response, we infected HFFs with an
RH(I) or RHDrop16 strain for three hours, or left cells uninfected,
and subsequently stimulated with IFNc for one hour, or left cells
unstimulated, and analyzed IRF1 protein levels by Western blot.
Figure 2. ROP16 activates STAT1 tyrosine phosphorylation and nuclear translocation. A, B. HFFs were infected with a GFP (green)
expressing RH(I), RHDrop16, Pru(II), Pru ROP16I, or CEP(III) strain, or left uninfected, for 3 hours, and 100 U/ml IFNc was added for the last two hours of
infection, or cells were left unstimulated. Cells were fixed, permeabilized, and stained with anti-phospho-STAT1Tyr (red) and Hoechst dye (nucleus,
blue). Nuclear localization of phospho-STAT1Tyr was quantified in at least 30 randomly selected cells infected with at least three parasites (A) and
a representative cell for each condition is shown (B). Scale bar represents 10 mm. This experiment was performed for each condition at least two
times with similar results. Data and standard deviation from one representative experiment are shown. Asterisk (*) indicates p,0.05 compared to
uninfected cells or as indicated by brackets.
doi:10.1371/journal.pone.0051448.g002
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While only RH(I) infection induced the tyrosine phosphorylation
of STAT1 in the absence of IFNc (Fig. 3A), RH(I) and RHDrop16
parasites both completely inhibited IFNc induced IRF1 expression
(Fig. 3A), indicating that ROP16 induced phospho-STAT1Tyr is
not transcriptionally active and that ROP16 is not required for the
ability of Toxoplasma infection to block IFNc induced STAT1
mediated gene expression. These results were confirmed in an
immunofluorescence assay. After two hours of infection with either
RH or RHDrop16 parasites, HFFs were subsequently stimulated
with IFNc for two hours, cells were fixed and permeabilized, and
IRF1 expression and STAT1 tyrosine phosphorylation were
visualized. As seen previously (Fig. 2A, B), after IFNc treatment,
cells infected with either RH or RHDrop16 had higher nuclear
phospho-STAT1Tyr than uninfected cells (Fig. 3B). But, as in the
Western blot results (Fig. 3A), both strains clearly inhibited IFNc
induced IRF1 expression (Fig. 3B).
In addition to STAT1 tyrosine phosphorylation at residue 701,
which is required for dimerization and nuclear translocation,
STAT1 also must be serine phosphorylated at residue 727 for full
transcriptional activity [35]. We wondered whether ROP16 or
type I, II, or III strains of Toxoplasma affect this serine
phosphorylation. It was previously shown that infection with
a Pru(II) strain of Toxoplasma does not interfere with IFNc induced
serine phosphorylation of STAT1 in HFFs [13], but this has not
been shown for any type I or III strains. We infected HFFs with an
RH(I), RHDrop16, Pru(II), or CEP(III) strain, or left cells
uninfected, for three hours, subsequently stimulated cells with
IFNc for one hour, or left cells unstimulated, and analyzed lysates
by Western blot. We first blotted for IRF1 as a control to confirm
that infection with any of these strains inhibited the IFNc induced
accumulation of IRF1 (Fig. 3C), as we have shown by
immunofluorescence (Fig. 1A, B, Fig. 3B). IRF1 was not inhibited
as strongly in this infection as compared to the previous Western
blot (Fig. 3A) due to a lower MOI. Additionally, Pru(II) infection
alone led to the induction of IRF1 protein, in concordance with
previous immunofluorescence experiments (Fig. 1A,B). We next
analyzed STAT1 phosphorylation in these lysates. Consistent with
our immunofluorescence data (Fig. 2A,B), infection with RH(I) or
CEP(III) led to a high level of phospho-STAT1Tyr as compared to
uninfected cells while a Pru(II) strain also induced phospho-
STAT1Tyr but to a lesser extent (Fig. 3C). Deletion of ROP16 from
RH almost completely abolished this tyrosine phosphorylation
(Fig. 3C). In addition, none of these strains inhibited the IFNc
induced accumulation of phospho-STAT1Tyr. Looking next at
STAT1 serine phosphorylation, we found that infection with any
of the Toxoplasma strains that we tested induced the serine
phosphorylation of STAT1 slightly, but none of these strains
strongly inhibited IFNc induced serine phosphorylation of STAT1
(Fig. 3C). These results indicate that ROP16 does not play a role
in serine phosphorylation of STAT1 and that type I, II, and III
strains do not differentially modulate STAT1 serine phosphory-
lation. Thus, Toxoplasma infection alone can induce low levels of
STAT1 serine phosphorylation independently of ROP16 and
ROP16 mediates the tyrosine phosphorylation and subsequent
nuclear translocation of STAT1, but this nuclear phospho-
STAT1Tyr701/Ser727 does not seem to be transcriptionally active.
Type I, II, and III Strains All Inhibit STAT1 Transcriptional
Activity
While our results demonstrate that type I, II, and III
parasites can all inhibit the IFNc induced expression of IRF1,
we have also shown that type I, II, and III parasites can
differentially modulate specific aspects of the IFNc/STAT1
signaling pathway. The type II GRA15 protein induces IRF1
Figure 3. ROP16-activated STAT1 is not transcriptionally
active. A. HFFs were infected with RH(I) or RHDrop16 parasites at an
MOI ,7, or left uninfected, for four hours. Cells were stimulated, or not,
with 100 U/ml human IFNc for the last hour of infection and cell lysates
were collected, run on an SDS-PAGE gel, and Western blotted for
phospho-STAT1Ser727, phospho-STAT1Tyr701, total STAT1a, IRF1, GAPDH
(host cell loading control) and SAG1 (parasite loading control). This
experiment has been performed three times with similar results. B.
HFFs were infected with RH(I) or RHDrop16 parasites for four hours,
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expression independently of STAT1 (Fig. 1D), and the rhoptry
kinase ROP16 induces STAT1 tyrosine phosphorylation (Fig. 2,
3). Additionally, the expression of many IFNc-regulated genes
can be induced by transcription factors other than STAT1; for
example the activation of IRF1 by GRA15 via NF-kB (Fig. 1A,
B) and the induction of Socs1 by ROP16 via STAT3 or 6 [25].
It is therefore difficult to interpret the modulation of the
STAT1 transcriptional response by different Toxoplasma strains
using the expression of particular genes as a read out. We
instead decided to use a stable STAT1 reporter cell line to
determine the ability of the Toxoplasma clonal lineages to
interfere with STAT1’s activity in the nucleus. One previous
report used two different luciferase reporters to demonstrate that
infection with Toxoplasma inhibits STAT1 transcriptional activity
[9]. However, one of these reporters was a stable reporter but
comprised the entire CIITA pIV promoter, containing binding
sites for IRF1, AP-1, and NF-GMa transcription factors and an
E-box site as well as a GAS site, making it difficult to determine
whether STAT1 activity itself was being affected by Toxoplasma
infection or if one of the other transcription factors was being
affected. The second reporter measured STAT1 activity more
clearly as it contained only a minimal GAS site, however the
reporter vector was transiently transfected into cells. Given
recent results that indicate that chromatin remodeling factors
such as Brahma-related gene (BRG)-1 are differentially recruited
to GAS sites after Toxoplasma infection to inhibit STAT1-
mediated transcription [14], and that Toxoplasma infection can
modulate chromatin modifications resulting in changes in gene
expression [36], a transient plasmid reporter that is not
integrated into the genome and does not have a normal
chromatin structure also may not be an accurate measure of
STAT1 transcriptional activity [37,38]. Additionally, potential
strain differences in the inhibition of these reporters were not
investigated.
We therefore developed a stable GAS reporter cell line in the
easily transduced HEK293 cell line to measure STAT1
transcriptional activity directly. Treatment of this GAS reporter
cell line with IFNc, but not IFNb, TNFa, or IL4, results in the
robust induction of luciferase activity (Fig. 4). We infected this
cell line with RH(I), RHDrop16, Pru(II), PruDgra15, or CEP(III)
parasites, stimulated the cells with IFNc, and measured the
induction of luciferase activity. Infection with any of these
strains significantly inhibited IFNc induced luciferase activity,
and the extent of this inhibition did not vary significantly
between the strains (Fig. 5A). These reporter experiments also
confirmed that while ROP16 can activate the tyrosine
phosphorylation and nuclear translocation of STAT1 (Fig. 2),
this STAT1 is not transcriptionally active; infection of this cell
line with any of these strains did not result in the induction of
luciferase (Fig. 5A). To verify that this ability to inhibit STAT1
transcriptional activity is common to the type I, II, and III
clonal lineages and not just RH(I), Pru(II), and CEP(III) strains,
we also infected this cell line with other representative strains
from these lineages, GT1(I), ME49(II), or VEG(III), as well as
RH(I) (Fig. 5B). Again, all of these strains were able to inhibit
IFNc induced luciferase activity. These results indicate that type
I, II, and III strains can all inhibit IFNc induced STAT1
transcriptional activity to a similar extent.
Type I, II, and III Strains All Inhibit Global IFNc Induced
Transcription
Although all Toxoplasma strains that we have tested inhibit
a stable GAS reporter cell line, we have seen that Toxoplasma
strains can differentially affect particular aspects of the IFNc
signaling pathway through GRA15 and ROP16, and it is
therefore unclear whether the ability to inhibit STAT1 activity
corresponds to the ability of type I, II, and III strains to
similarly inhibit global IFNc induced gene expression. We
therefore analyzed the effect of infection with an RH(I), Pru(II),
or CEP(III) strain on IFNc induced transcription using
microarray analysis. As more genes have been found to be
induced by IFNc in macrophages than fibroblasts [13,14], we
pre-infected a murine macrophage cell line (RAW264.7) with
the above strains for 24 hours, adding IFNc for the last six
hours. We isolated RNA from these cells as well as uninfected
control cells, with and without IFNc stimulation, and analyzed
gene expression with Affymetrix microarrays. In this macro-
phage cell line, 514 genes were more than 2-fold upregulated by
IFNc treatment, while the expression of 481 genes was more
than 2-fold repressed (Fig. 6). In the pre-infected samples, 431
of the 514 induced genes were at least 2-fold inhibited by at
least one strain, with 314 genes being inhibited by all strains
(Fig. 6). Interestingly, the expression of genes that are important
for control of Toxoplasma infection, Nos2 [39], Iigp1/Irga6
[40,41], Iigp2/Irgm2 [42], and Tgtp/Irgb6 [42] were at least 2-
fold inhibited by all three strains. Of the 481 IFNc repressed
genes, the repression of 312 of them was more than 2-fold
inhibited by at least one strain while 147 genes were inhibited
by all three strains (Fig. 6). It seems then that while Toxoplasma
strains may differentially inhibit small subsets of IFNc re-
sponsive genes, all three of the clonal lineages significantly
inhibit global IFNc induced gene expression.
stimulated with 100 U/ml IFNc for the last two hours of infection, fixed,
and stained with anti-IRF1 (red), anti-phospho-STAT1Tyr (green), and
Hoechst dye (nucleus, blue). Parasites also express GFP (green). Scale
bar represents 10 mm. This experiment was performed three times with
similar results. C. HFFs were infected with RH(I), RHDrop16, Pru(II), or
CEP(III) parasites at an MOI ,1, or left uninfected, for four hours. Cells
were stimulated, or not, with 100 U/ml human IFNc for the last hour of
infection and cell lysates were collected, run on an SDS-PAGE gel, and
Western blotted for phospho-STAT1Ser727, phospho-STAT1Tyr701, total
STAT1a, IRF1, GAPDH (host cell loading control) and SAG1 (parasite
loading control). This experiment has been performed two times with
similar results.
doi:10.1371/journal.pone.0051448.g003
Figure 4. Characterization of HEK293 GAS reporter cell line. A
HEK293 GAS luciferase reporter cell line was left unstimulated or
stimulated with 100 U/ml IFNc, 100 U/ml IFNb, 20 ng/ml TNFa, or
50 ng/ml IL4. Cells were lysed 6–20 hours later and luciferase activity
was measured. Average luciferase induction normalized to unstimu-
lated cells from three experiments is shown and error bars represent
standard error.
doi:10.1371/journal.pone.0051448.g004
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Discussion
The expression level of many genes is regulated by multiple
transcription factors allowing more precise control and respon-
siveness to varying stimuli. While we find that strains representing
three Toxoplasma clonal lineages, types I, II, and III, can all inhibit
IFNc induced STAT1 transcriptional activity, these strains also
differentially modulate certain IFNc responsive genes through the
activity of at least two known polymorphic effectors, GRA15 and
ROP16. In studying the ability of Toxoplasma to inhibit the IFNc
response, the choice of readout for IFNc induced gene expression
is therefore very important, as some IFNc responsive genes are
also activated by Toxoplasma through GRA15, ROP16, and likely
other secreted proteins.
GRA15II-mediated activation of NF-kB can induce expression
of IRF1, and the levels of IRF1 in Pru(II) infected cells stimulated
with IFNc are virtually identical to those of Pru(II) infected cells
that were not stimulated (Fig. 1A). This indicates that Pru(II)
parasites can inhibit IFNc induced expression of IRF1, even
though they induce IRF1 through GRA15-mediated activation of
NF-kB (Fig. 1A, D). Similarly, ROP16I/III induces Socs1 expres-
sion by 10-fold in murine BMDM [25], likely through STAT3 or
STAT6. But, our microarray data from the murine macrophage
RAW264.7 cell line shows that pre-infection with RH(I) parasites
Figure 5. All three clonal lineages of Toxoplasma inhibit STAT1-mediated gene expression. A, B. A HEK293 GAS luciferase reporter cell
line was infected with RH(I), RHDrop16, GT1(I), Pru(II), PruDgra15, ME49(II), CEP(III), or VEG(III) parasites, or left uninfected, and subsequently
stimulated, or not, with 100 U/ml IFNc. Cells were then lysed and luciferase activity was measured. Results are from 2–8 experiments per condition,
with a pre-infection time of 1–5 hours followed by a stimulation of 12–24 hours, and represent the average induction over uninfected, unstimulated
samples. Error bars represent SEM. Asterisk (*) indicates p,0.05 compared to uninfected cells in the same condition.
doi:10.1371/journal.pone.0051448.g005
Figure 6. All three clonal lineages of Toxoplasma inhibit global IFNc-induced gene expression. RAW264.7 macrophages were infected
with RH(I), Pru(II), or CEP(III) parasites, or left uninfected (UI) for 24 hours with 100 U/ml IFNc added for the last 6 hours of infection, and host gene
expression was analyzed by microarray analysis. Greater than 2-fold IFNc induced (left) and repressed (right) genes were determined from the
uninfected samples. Boxplots are shown of the log2 expression of these genes in all samples. Data are from two arrays for the uninfected conditions
and one array for each infected sample.
doi:10.1371/journal.pone.0051448.g006
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can still inhibit IFNc induced Socs1 transcript by two-fold. Thus,
although Toxoplasma is able to inhibit the STAT1-mediated
induction of genes such as IRF1 and Socs1, it does not inhibit
the expression of these genes activated by other transcription
factors. This indicates that whatever mechanism Toxoplasma
employs to inhibit the IFNc-induced transcriptional response
must specifically target STAT1-mediated transcriptional activa-
tion of genes.
While neither GRA15 nor ROP16 affects the ability of
Toxoplasma strains to inhibit the STAT1-mediated global induction
of IFNc responsive gene expression, it is unclear how large of an
effect GRA15 and ROP16 have on subsets of IFNc responsive
genes as our experiments were done in a different cell line than
previous transcriptional analyses on GRA15 and ROP16.
However, IRF1 is an important secondary transcription factor in
the response to IFNc. Additionally, NF-kB is likely to co-regulate
other IFNc responsive genes besides IRF1. A significant number
of genes induced by both IFNc and Pru(II) infection are GRA15-
regulated (Data S1). While one microarray analysis in HFFs found
that IFNc responsive genes that were also induced by Pru(II)
infection alone were associated with TNFa signaling and included
many NF-kB target genes [13], another microarray analysis in
murine BMDM did not find an enrichment in NF-kB target genes
among genes induced by both IFNc and another type II strain,
NTE [14]. However, it is unknown whether the NTE(II) strain has
an active copy of GRA15 and activates NF-kB.
The strongest effect of ROP16 on IFNc signaling seems be on
the phosphorylation status of STAT1 (Fig. 2). Since ROP16
directly tyrosine phosphorylates STAT3 and STAT6 [20,21], it is
likely that tyrosine 701 on STAT1 is also a direct target. It seems
that either the affinity or catalytic efficiency of ROP16 for STAT1
is lower than for at least STAT6 because clear phospho-STAT1Tyr
activation was only observed in cells infected with at least three
parasites, whereas only one parasite needs to inject its rhoptry
contents into a host cell to activate STAT6 [43].
It is still unclear why we observe a higher level of IFNc induced
phospho-STAT1Tyr after pre-infection with any strain of Toxo-
plasma (Fig. 2A). This phenotype is not dependent on ROP16 as it
also occurs in RHDrop16 infected cells. The transcripts of the main
components of this pathway, IFNc receptor 1 and 2, JAK1 and 2,
and STAT1, are not upregulated by type I Toxoplasma infection in
HFFs, according to previous microarray data [19]. Additionally,
SOCS proteins that can downregulate JAK and STAT1
phosphorylation are actually induced by Toxoplasma infection
[12], and the expression of the protein tyrosine phosphatases
(PTPs) that are known to dephosphorylate JAK1, JAK2, or
STAT1 [44] are not downregulated by infection alone [19].
Our data suggest that the type I, II, and III strains use a similar
mechanism to inhibit STAT1 transcriptional activity in the
nucleus. This inhibition is independent of how STAT1 is
activated; Toxoplasma can also inhibit the activity of ROP16
induced phospho-STAT1Tyr, and this interference is specific for
STAT1, as ROP16-activated STAT3 and STAT6 are transcrip-
tionally active [18,25]. A recent study, which focused mainly on
the IFNc induced expression of CIITA and MHC class II genes,
concluded that Toxoplasma inhibits IFNc induced gene expression
through impaired BRG-1 chromatin remodeling [14]. Although
that may be the mechanism for CIITA, the IFNc induced
expression of IRF1 does not require BRG-1 remodeling [45]. It is
therefore important for future studies to determine the mechanism
by which Toxoplasma inhibits the STAT1-mediated induction of
primary response genes such as IRF1.
Supporting Information
Data S1 GRA15-regulated IFNc responsive genes. 374
genes induced by IFNc treatment and by Pru infection in
a published microarray analysis and also present in a microarray
analysis of HFFs infected with GRA15-deficient and GRA15-
overexpressing Toxoplasma strains are listed. Whether these genes
were also found to be at least two-fold GRA15-regulated in at least
one parasite genetic background is also indicated.
(XLSX)
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